Back
Arbutus Biopharma Corp ABUS · Insights
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeuti... Price3.72
Market Cap736.95 M
Float150.62 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro